Barclays analyst Matt Miksic maintains Johnson & Johnson (NYSE:JNJ) with a Equal-Weight and raises the price target from $158 to $162.
Barclays analyst Matt Miksic maintains Johnson & Johnson (NYSE:JNJ) with a Equal-Weight and raises the price target from $158 to $162.